PeptidePedia The community reference

Information for AmbioPharm

Page information·measured at build time

Technical and provenance information about AmbioPharm. All figures on this page are measured from the emitted page rather than declared.

Basic information

Display titleAmbioPharm
Default sort keyAmbioPharm
NamespaceArticle (main)
Page kindOrganisation
Page length (source, bytes)17,175
Rendered word count2,802
Internal wiki links on the page53
Defined citations8
Top-level sections10
Subsections1
Tables1
Figures0
InfoboxYes — organisation
Maintenance bannersprimarysources
Indexing by robotsAllowed

Edit history

Page creatorRetinopathyRex
Date of page creation2 October 2025
Latest editorVerifyFirstVida
Date of latest edit23 July 2026
Total number of edits37
Total number of distinct authors31
Minor edits10
Automated (bot) edits4
Recent number of edits (last 90 days)8
Talk page posts12

Principal authors

EditorEditsShareDeclared focus
VerifyFirstVida25.4%third-party testing and certificates of analysis
ArchiveBot25.4%policy, notability and deletion
CheckSumChase25.4%third-party testing and certificates of analysis
ForgeryFinder25.4%third-party testing and certificates of analysis
StubSorterBot25.4%categorisation and navigation
DrTitration25.4%dosing, titration and injection practice
RetinopathyRex12.7%adverse effects and clinical safety
Compounding_Cate12.7%compounding law and drug regulation
SemaglutideSasha12.7%GLP-1 receptor agonists and related compounds
BetaCellBoyd12.7%incretin biology and receptor pharmacology
VerifyVesna12.7%third-party testing and certificates of analysis
GMP_Gita12.7%compounding law and drug regulation

Category membership